Rank 62 • MedTech & Devices
RefleXion Medical
Develops a biology-guided radiotherapy system that combines PET imaging with radiation delivery to target multiple tumors.
Visit website- Signal Score
- 87.1
- Total raised
- $450M
- Stage
- Series D+
- Founded
- 2009
- Headquarters
- Hayward, USA
- Region
- North America
Their signal
RefleXion's revolutionary approach turns cancer biomarkers into real-time therapeutic guides. This allows precision treatment of moving metastatic tumors, a milestone achievement in oncological medical devices.
Signal Score 87.1editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in MedTech & Devices
Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.